Patents by Inventor Janet Sredy

Janet Sredy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
    Publication number: 20120065203
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 15, 2012
    Applicant: The Institute for Pharmaceutical Discovery, LLC
    Inventors: Janet Sredy, Jorge Jacot
  • Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
    Publication number: 20100324105
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Inventors: Janet Sredy, Jorge Jacot
  • Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
    Publication number: 20060074114
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: November 15, 2005
    Publication date: April 6, 2006
    Inventors: Janet Sredy, Jorge Jacot
  • Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
    Patent number: 6964980
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: March 26, 2003
    Date of Patent: November 15, 2005
    Assignee: The Institute for Pharmaceutical Discovery, Inc.
    Inventors: Janet Sredy, Jorge Jacot
  • Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
    Publication number: 20030216452
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: March 26, 2003
    Publication date: November 20, 2003
    Applicant: The Institute for Pharmaceutical Discovery, Inc.
    Inventors: Janet Sredy, Jorge Jacot
  • Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
    Publication number: 20030171405
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds. Further, disclosed are combinations of an angiotensin converting enzyme inhibitor and a substituted indole acetic acid.
    Type: Application
    Filed: February 18, 2003
    Publication date: September 11, 2003
    Applicant: The Institutes for Pharmaceutical Discovery LLC., A Corporation of the State of Delaware
    Inventors: Janet Sredy, Michael C. Van Zandt
  • Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
    Patent number: 6555568
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: April 29, 2003
    Assignee: Institute for Pharmaceutical Discovery, L.L.C.
    Inventors: Janet Sredy, Jorge Jacot
  • Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
    Patent number: 6521659
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds. Further, disclosed are combinations of an angiotensin converting enzyme inhibitor and a substituted indole acetic acid.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: February 18, 2003
    Assignee: Institute for Pharmaceutical Discovery, LLC
    Inventors: Janet Sredy, Michael C. Van Zandt
  • Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
    Publication number: 20010041722
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds. Further, disclosed are combinations of an angiotensin converting enzyme inhibitor and a substituted indole acetic acid.
    Type: Application
    Filed: February 28, 2001
    Publication date: November 15, 2001
    Inventors: Janet Sredy, Michael C. Van Zandt